SCHEMBL23966211

SCHEMBL23966211

C=NN(/C=C\C)c1ccc(Cn2c(=O)n(C)c3cnc(Cl)nc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
USP1 O94782 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29333283 0.79 USP1 (0.63) USP1
SCHEMBL1693503 0.76 HPGD (0.54) USP1
SCHEMBL18865609 0.70 USP1 (0.67) USP1
SCHEMBL29691093 0.70 USP1 (0.67) USP1
SCHEMBL29691169 0.69 USP1 (0.71) USP1
SCHEMBL18865596 0.69 USP1 (0.71) USP1
SCHEMBL31546299 0.67 USP1 (0.47) USP1
SCHEMBL30677051 0.67 USP1 (0.48) USP1
SCHEMBL30328166 0.65 HPGD (0.38) USP1
SCHEMBL4184836 0.65 PDE4A (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161848-B2 Purinones as ubiquitin-specific protease 1 inhibitors FORMA THERAPEUTICS, INC. (US) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161848-B2 Purinones as ubiquitin-specific protease 1 inhibitors USP1, UBA1, UBXN1 USP1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.